Gene L. Dodaro, Comptroller General of the United States and head of the U.S. Government Accountability Office (GAO), today announced the appointment of 15 members to the Methodology Committee of the Patient-Centered Outcomes Research Institute (PCORI).
“The
Methodology Committee has the responsibility of helping PCORI develop
and update methodological standards and guidance for comparative
clinical effectiveness research. The men and women named today bring
impressive credentials and experience to this important task,” Dodaro
said.
The
Patient Protection and Affordable Care Act authorized PCORI as a
non-profit corporation to assist patients, clinicians, purchasers, and
policymakers in making informed health decisions by providing quality,
relevant evidence on how best to prevent, diagnose, treat, and monitor
diseases and other health conditions.
The
Act directs the Comptroller General to appoint up to 15 members to
PCORI’s Methodology Committee. In addition to the 15 members appointed
today, the Director of the Agency for Healthcare Research and Quality
and the Director of the National Institutes of Health, or their
designees, will also serve on the committee.
The members appointed to the Methodology Committee are:
• Naomi Aronson, PhD, Executive Director, Blue Cross and Blue Shield Association Technology Evaluation Center.
•
Ethan Basch, MD, MSc, medical oncologist and health services
researcher, Department of Medicine and Department of Epidemiology,
Memorial Sloan-Kettering Cancer Center.
• Alfred Berg, MD, MPH, Professor, Department of Family Medicine, University of Washington.
•
David Flum, MD, MPH, Professor, Department of Surgery and Adjunct
Professor, Department of Health Services, University of Washington
Schools of Medicine and Public Health; Attending physician, General
Surgery, University of Washington Medical Center.
•
Sherine Gabriel, MD, MSc, Professor of Medicine and of Epidemiology,
and the William J. and Charles H. Mayo Professor, Mayo Clinic.
•
Steven Goodman, MD, PhD, Professor of Oncology, of Pediatrics, of
Epidemiology and of Biostatistics, Johns Hopkins School of Medicine and
Bloomberg School of Public Health.
•
Mark Helfand, MD, MS, MPH, Professor of Medicine and of Medical
Informatics and Clinical Epidemiology, Oregon Health & Science
University; Staff physician, Portland VA Medical Center.
•
John Ioannidis, MD, DSc, the C.F. Rehnborg Professor in Disease
Prevention, Professor of Medicine and Director, Stanford Prevention
Research Center, Stanford University School of Medicine.
•
David Meltzer, MD, PhD, Director, Center for Health and the Social
Sciences, Chief of the Section of Hospital Medicine, and Associate
Professor, Department of Medicine, Department of Economics, and Graduate
School of Public Policy Studies, University of Chicago.
•
Brian Mittman, PhD, Director, VA Center for Implementation Practice and
Research Support, Department of Veterans Affairs Greater Los Angeles
Healthcare System.
•
Robin Newhouse, PhD, RN, Assistant Dean, Doctor of Nursing Practice
Program and Associate Professor, Organizational Systems and Adult
Health, University of Maryland School of Nursing.
•
Sharon-Lise Normand, MSc, PhD, Professor of Health Care Policy, Harvard
Medical School and Professor of Biostatistics, Harvard School of Public
Health.
•
Sebastian Schneeweiss, MD, ScD, Associate Professor, Department of
Medicine, Harvard Medical School and Associate Professor, Department of
Epidemiology, Harvard School of Public Health; Vice Chief and
Director, Drug Evaluation and Outcomes Research, Division of
Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s
Hospital.
•
Mary Tinetti, MD, Professor of Medicine, Epidemiology, and Public
Health, Division of Geriatrics, Yale University School of Medicine;
Director, Program on Aging, Yale University School of Medicine.
•
Clyde Yancy, MD, MSc, Chief, Cardiology, Northwestern University
Feinberg School of Medicine; Associate Director, The Bluhm
Cardiovascular Institute, Northwestern Memorial Hospital.
Attached
are brief biographies of the new committee members. The official
announcement of the appointments will be published in the Federal
Register. For more information, contact Mary Giffin of GAO's Health Care
team at (202) 512-7114 or Chuck Young in GAO's Office of Public Affairs
at (202) 512-4800, or visit the GAO Health Care Advisory Committees web
page at http://www.gao.gov/about/hcac/index.html.
The Act requires the Comptroller General to disclose any conflicts of
interest in appointing members of the Methodology Committee on GAO’s
website. Please click here (http://www.gao.gov/about/hcac/pcori_methodology_comm_conflicts.html) for more information.
The Comptroller General is required to disclose any conflicts of interest on GAO’s website. Please click here (http://www.gao.gov/about/hcac/pcori_methodology_comm_conflicts.html)
for a list of the Methodology Committee members’ associations the
Comptroller General has determined fit within the Act’s definition of a
“conflict of interest.”
No comments:
Post a Comment